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Abstract We report a rare case of a woman with bilateral
papillary cystadenomata of the broad ligament with von
Hippel–Lindau disease (VHL) (other manifestations: capil-
lary hemangioblastomas of the spinal cord). Patient surveil-
lance is important, because in the course of VHL-associated
tumors malignant lesions may arise that are relevant for the
prognosis.
Keywords Von Hippel–Lindau disease · Papillary 
cystadenoma of the mesosalpinx
Introduction
Von Hippel–Lindau disease (VHL) was Wrst described in 1926
as an inherited disease, characterized by tumors of the retina,
brain, kidney, adrenal gland, and pancreas. Recently the VHL
gene was identiWed as a tumor suppressor gene on the short
arm of chromosome 3 (3p25-26). VHL disease is an autosomal
dominantly inherited multisystemic tumor syndrome due to a
gene mutation with an incidence of one in 36,000 live births
[1]. In 20% of cases de novo mutations occur [2]. The muta-
tions cause a situation analogous to hypoxia with an increase
in various growth and angiogenic factors [3].
AVected individuals are at high risk for developing vari-
ous benign and malignant tumors. Lesions in VHL disease
tend to be multiple and bilateral in paired organs (Table 1)
[1, 4–6]. Though rarely described in the literature (n = 4),
a benign adnexal papillary tumor of probable mesonephric
origin (APMO) is highly signiWcantly associated with VHL
disease. The WHO classiWcation diVerentiates between two
main clinical types, based on the risk for developing a
pheochromocytoma and/or renal cell carcinoma and is
related to the type of mutation (Table 2) [1, 7]. 
Most tumors develop at younger age, i.e. between 20 and
40 years. The penetrance of the disease is about 96% by the
age of 60 years with renal cell cancer in 69%, retinal tumor
in 70% and cerebellar hemangioblastoma in 85% [1, 6].
Metastases determine the prognosis and can be found in
patients with renal cell carcinoma, rarely in pheochromocy-
tomas or islet cell tumors. Intracerebral hemorrhages due to
bleeding from carcinomas or hemangioblastomas of the
brain are the main cause of death [4].
Improved surveillance, earlier diagnosis of the lesions
with modern imaging (MRI), improvements in treatment
and increased knowledge of this disease have resulted in an
improved prognosis and reduced rates of complications. An
interdisciplinary team is beneWcial for optimal assessment,
treatment, and follow-up. It is also recommended that the
family of the index patient is examined, because individu-
als with a predisposition for an inherited tumor syndrome,
such as VHL disease, beneWt from early screening at
around 11 years of age, ophthalmologic examination, cate-
cholamine testing, and magnetic resonance imaging [4].
Case report
A woman aged 23, nulligravida, underwent a gynecological
examination at our institution, because of lower abdominal
pain of unclear etiology. Ultrasonographic examination
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344 Arch Gynecol Obstet (2010) 282:343–346revealed a partly solid, partly cystic mass of 3.5 cm diame-
ter in the right adnexal region (Fig. 1). Ca-125 was within
normal limits (15.9 U/ml). Laparoscopy was performed and
a cystic tumor was found in the right mesosalpinx (Fig. 2)
and removed completely. In the left mesosalpinx a smaller
(8 mm diameter) cystic tumor was detected and subse-
quently removed. On both sides ovaries and fallopian tubes
were unaVected and could be preserved.
Histological examination revealed bilateral clear cell pap-
illary cystadenomas of the mesosalpinx. The tumors were
composed of tightly packed papillae with loose or dense
Wbrous cores, covered by a monolayered epithelium (Fig. 3).
These Wndings prompted genetic testing on the adnexal pap-
illary tumor of probable mesonephric origin (APMO) and
showed a point mutation P86L on the exon 1 of the VHL
gene. The patient has been counseled accordingly.
Five years before, the patient had undergone a laminec-
tomy of thoracic vertebrae 2 and 3 for symptomatic capil-
lary hemangioma with insertion of syringoperitoneal
drainage (Fig. 4). The size of the hemangioblastoma of the
thoracic vertebral column at that time was 3 £ 1.5 cm. Dur-
ing follow-up, MRI now shows two additional similar
lesions at the cervical vertebral body IV (1 £ 1 cm) and the
sacral body which until now have been treated conserva-
tively and examined every 6–12 months (picture not
shown).
Comment
Papillary cystadenomas of the mesosalpinx are rare benign
lesions. Bilaterality can be a diagnostic hint of VHL disease
[1]. Surgery is necessary if symptoms occur. The APMO is
histologically identical to the papillary cystadenoma of the
epididymis in males, where it is usually diagnosed easier
[8, 9]. With regard to long-term consequences proper fol-
low-up concerning renal cell carcinoma is mandatory,
because the risk of metastatic disease increases with tumor
size [4]. Vice versa proper surveillance of the gonadal
region in VHL patients is necessary, since metastasis of
renal cell carcinomas to the adnexae and epididymes are
described. These metastases might even develop within
existing VHL lesions, such as in hemangioblastoma of the
brain or in cystadenomas of the epididymis, the adrenal
gland, and in the gall bladder [7].
The histological similarity between papillary cystade-
noma and renal cell carcinoma can be explained by the
similar phylogenetic origin of renal tubules, ductules eVer-
entes, and mesonephric remnants [10]. Thus papillary cys-
tadenomas can be found intra- and extraperitoneally in
remnant parts of the mesonephric duct including the broad
ligament, the mesosalpinx, along the lateral wall of the
uterus and in the wall of the vagina [11, 12]. There are
reports on VHL tumors of both Mullerian and WolYan ori-
gin containing numerous glands (characterized by tall
columnar cells) [9, 13]. Interestingly, these lesions might
be associated with a histological identical papillary middle
ear/temporal bone tumor [11].
Table 1 Typical VHL lesions
Frequency
(%)
Onset
(years)
CNS
Retinal hemangioblastoma 10–72 25–33
Endolymphatic sac tumor
Craniospinal hemangioblastoma
Visceral
Renal cell carcinoma 25–70 30–39
Pheochromocytoma
Pancreatic tumor 
(cyst, serous cystadenomas, 
neuroendocrine tumor)
Cystadenoma of epididymis 
or broad ligament
Table 2 WHO classiWcation of VHL disease
Type 1 Low risk for pheochromocytoma, hemangioblastoma, 
renal cell cancer, pancreatic neoplasms and cysts
Type 2A Pheochromocytoma, hemangioblastoma, low risk 
for renal cell carcinoma and pancreatic tumors
Type 2B Pheochromocytoma, hemangioblastoma, high risk 
for renal cell carcinoma and pancreatic tumors
Type 2C Predominantly pheochromocytoma, very limited 
risk of hemangioblastoma and of renal cell cancer
Fig. 1 Doppler ultrasonographic scan of the papillary cystadenoma of
the right adnex region (arrow indicates the papillary part of the tumor)123
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adnexae and in the spinal column. We report this case
because only the gynecological Wndings prompted the
deWnitive genetic tests. Our case report intends to make
gynecologists aware that APMO could be a Wrst manifesta-
tion of VHL disease. Since early diagnosis is relevant for
long-term prognosis of the patient and its family, the gyne-
cologist should trigger genetic tests and imaging studies to
prove or rule out VHL disease.
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